Cargando…
A Tau Pathogenesis-Based Network Pharmacology Approach for Exploring the Protections of Chuanxiong Rhizoma in Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common cause of neurodegenerative dementia and one of the top medical concerns worldwide. Currently, the approved drugs to treat AD are effective only in treating the symptoms, but do not cure or prevent AD. Although the exact causes of AD are not understood, it...
Autores principales: | Zeng, Peng, Su, Hong-Fei, Ye, Chao-Yuan, Qiu, Shuo-Wen, Shi, Anbing, Wang, Jian-Zhi, Zhou, Xin-Wen, Tian, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068950/ https://www.ncbi.nlm.nih.gov/pubmed/35529440 http://dx.doi.org/10.3389/fphar.2022.877806 |
Ejemplares similares
-
Key Phytochemicals and Biological Functions of Chuanxiong Rhizoma Against Ischemic Stroke: A Network Pharmacology and Experimental Assessment
por: Zeng, Peng, et al.
Publicado: (2021) -
Reveal the Antimigraine Mechanism of Chuanxiong Rhizoma and Cyperi Rhizoma Based on the Integrated Analysis of Metabolomics and Network Pharmacology
por: Zhu, Zhiyao, et al.
Publicado: (2022) -
Exploring the Potential Mechanism of Chuanxiong Rhizoma Treatment for Migraine Based on Systems Pharmacology
por: Wen, Xianhua, et al.
Publicado: (2021) -
Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats
por: Li, Haigang, et al.
Publicado: (2023) -
Nephroprotective mechanisms of Rhizoma Chuanxiong and Radix et Rhizoma Rhei against acute renal injury and renal fibrosis based on network pharmacology and experimental validation
por: Li, Jun, et al.
Publicado: (2023)